Full-Time
Updated on 1/15/2025
Develops monoclonal antibodies for infectious diseases
$134.5k - $169.5kAnnually
Mid, Senior
No H1B Sponsorship
San Francisco, CA, USA
Requires onsite presence in San Francisco for at least 4 days per week.
Vir Biotechnology develops treatments for infectious diseases by leveraging the immune system. They use a platform that combines monoclonal antibodies with machine learning to create a database of human antibodies, which helps in designing effective medicines. Their focus includes therapies for hepatitis B, HIV, and various viral infections like influenza and COVID-19. The company aims to transform lives by addressing unmet medical needs through innovative therapies.
Company Stage
IPO
Total Funding
$640.6M
Headquarters
San Francisco, California
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
Comprehensive healthcare coverage
Employer matched 401(k)
Employee stock purchase plan
Childcare assistance
Tuition reimbursement